AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Defensive Interval Ratio

Latest as of December 2025: 5 days

AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Defensive Interval Ratio of 5 days as of December 2025. Defensive assets of €6.40 Million (cash €-, short-term investments €-, receivables €6.40 Million) cover 5 days of daily cash needs of €1.17 Million/day. Check 3FMA goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

5 days
Days of operational coverage

Defensive Assets

€6.40 Million
Cash + ST Investments + Receivables

Daily Cash Need

€1.17 Million
Current Liabilities ÷ 365

Current Liabilities

€428.55 Million
EUR

AEST.MED.INT.HLD.SP.ADR/3 Defensive Interval Ratio (2021–2025)

This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 5 days, meaning defensive assets of €6.40 Million can fund 5 days of operations without new revenue. Also explore 3FMA net assets growth trend to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see AEST.MED.INT.HLD.SP.ADR/3 (3FMA) total market value.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 5 days €6.40 Million €1.17 Million/day €- €- ▼ -3 days
2024 8 days €8.79 Million €1.10 Million/day €- €- ▼ -1 days
2023 9 days €9.84 Million €1.13 Million/day €- €- ▲ +5 days
2022 4 days €6.19 Million €1.49 Million/day €- €- ▼ -1 days
2021 5 days €7.77 Million €1.48 Million/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)